China Sinopharm's 100 million doses of COVID-19 vaccines supplied globally

Published On 2021-03-28 04:45 GMT   |   Update On 2021-03-28 04:45 GMT

Beijing: Two COVID-19 vaccines developed by subsidiaries of China National Pharmaceutical Group (Sinopharm) have hit a combined 100 million doses of supply around the world, a Sinopharm affiliate said late on Friday.

Over 80 million doses of the two vaccines were administered, China National Biotec Group Company (CNBG) said on social media.

Sinopharm had said it could reach an annual capacity of 1 billion doses in 2021 and aims to expand capacity to 3 billion doses per year, without specifying the timeframe for the target.

Another Chinese vaccine maker Sinovac Biotech said on Monday it had supplied 160 million doses of its COVID-19 vaccine to 18 countries and regions, including China, with over 70 million shots injected.

Read also: Sinovac raises USD 500 million funding for COVID-19 Vaccine Development

The three vaccines, along with a fourth vaccine from CanSino Biologics Inc, have been approved in China for general public use. A fifth vaccine developed by the Institute of Microbiology Chinese Academy of Sciences has gained clearance for limited emergency use.

Read also: Indonesia gets 1.8 million doses of Sinovac Biotech COVID-19 vaccine



Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News